Wow. The monoclonal antibody race is on fire.

I sure hope we can get results soon and be a part of this. It’s a little daunting to have these monster global companies (and all of their resources) chasing the same path to a therapeutic.

I guess the key question is - are we in the mix on this? Wasn’t mentioned on the call - but understandably given it wasn’t public. Sure hope we are.